Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Oct 16;329(7471):909-12.
doi: 10.1136/bmj.329.7471.909.

Managing comorbidities in patients at the end of life

Affiliations
Review

Managing comorbidities in patients at the end of life

James Stevenson et al. BMJ. .

Abstract

Chronic conditions require careful management in patients who develop a life limiting illness. Doctors need to consider both the physical and psychological effects of treatment

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comorbidity in patients with terminal illness needs careful management Credit: JOHN COLE/SPL
Figure 2
Figure 2
Factors influencing the likelihood of continuing treatment for medical comorbidities in patients with life limiting illness, and examples of conditions in each category

Comment in

References

    1. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious comorbidity among unselected cancer patients newly diagnosed in southeastern part of the Netherlands in 1993-1996. J Clin Epidemiol 1999;52: 1131-6. - PubMed
    1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002;287: 337-44. - PubMed
    1. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996;14: 447-50. - PubMed
    1. Mannesse CK, Derkx FHM, De Ridder MAJ, Man in't Veld AJ, Van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29: 35-9. - PubMed
    1. Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection. Ann Intern Med 2000;133: 430-4. - PubMed